FLORESTA, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 3.668
EU - Europa 2.121
AS - Asia 1.968
SA - Sud America 360
AF - Africa 281
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.406
Nazione #
US - Stati Uniti d'America 3.613
IT - Italia 1.402
SG - Singapore 832
CN - Cina 737
BR - Brasile 321
IE - Irlanda 284
CI - Costa d'Avorio 228
KR - Corea 186
DE - Germania 86
RU - Federazione Russa 60
VN - Vietnam 56
GB - Regno Unito 48
CA - Canada 38
FI - Finlandia 38
IN - India 31
SE - Svezia 30
CZ - Repubblica Ceca 27
NL - Olanda 27
FR - Francia 26
UA - Ucraina 23
BD - Bangladesh 20
HK - Hong Kong 17
ID - Indonesia 17
SN - Senegal 17
TR - Turchia 15
ES - Italia 14
PL - Polonia 14
JP - Giappone 13
AR - Argentina 12
MX - Messico 11
AT - Austria 10
CH - Svizzera 10
EC - Ecuador 10
ZA - Sudafrica 10
AU - Australia 6
CO - Colombia 6
IQ - Iraq 6
NG - Nigeria 6
VE - Venezuela 6
BE - Belgio 5
EG - Egitto 5
MA - Marocco 5
PK - Pakistan 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
AL - Albania 3
BG - Bulgaria 3
CL - Cile 3
ET - Etiopia 3
GR - Grecia 3
KZ - Kazakistan 3
LB - Libano 3
TN - Tunisia 3
IR - Iran 2
JO - Giordania 2
MY - Malesia 2
SA - Arabia Saudita 2
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EU - Europa 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
LI - Liechtenstein 1
LT - Lituania 1
LU - Lussemburgo 1
ME - Montenegro 1
MK - Macedonia 1
MZ - Mozambico 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PE - Perù 1
PH - Filippine 1
PS - Palestinian Territory 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SV - El Salvador 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 8.406
Città #
Dallas 801
Santa Clara 560
Singapore 514
Chandler 439
Catania 365
Hefei 359
Chicago 296
Dublin 284
Abidjan 228
Seoul 184
Civitanova Marche 152
Ashburn 143
Boardman 134
Houston 122
Beijing 100
Rome 69
Cambridge 59
Lawrence 59
Los Angeles 58
Naples 55
Andover 52
Bremen 39
Milan 36
The Dalles 35
Columbus 34
Nanjing 34
Des Moines 32
San Giovanni la Punta 26
Lappeenranta 25
Palermo 25
Jacksonville 24
São Paulo 23
Council Bluffs 22
Munich 22
Brno 21
Dong Ket 19
Florence 19
Sala Baganza 18
Toronto 18
Dakar 17
Messina 17
New York 16
Bari 15
Misterbianco 15
Salerno 15
Wilmington 15
Boydton 14
Hong Kong 14
Washington 14
Ho Chi Minh City 13
Jakarta 13
San Francisco 13
Acireale 12
Brooklyn 12
Phoenix 12
Tokyo 12
Hanoi 11
Porto San Giorgio 11
Saint Petersburg 11
Groningen 10
Lecce 10
Rio de Janeiro 10
Villafranca Tirrena 10
Belpasso 9
Mascalucia 9
Warsaw 9
Aci Catena 8
Belo Horizonte 8
Curitiba 8
Dhaka 8
Gravina di Catania 8
Nanchang 8
Ottawa 8
Redmond 8
Bologna 7
Foggia 7
Fortaleza 7
Hebei 7
Helsinki 7
Jiaxing 7
London 7
Manchester 7
Paternò 7
Seattle 7
Abuja 6
Amsterdam 6
Boston 6
Guangzhou 6
Istanbul 6
Modica 6
Shenyang 6
Tianjin 6
Turku 6
Villamagna 6
Avola 5
Centro 5
Chennai 5
Grafing 5
Guarulhos 5
Jinan 5
Totale 6.068
Nome #
Discovery of Novel Acetamide-Based Heme Oxygenase-1 Inhibitors with Potent in Vitro Antiproliferative Activity 138
[1]Benzothieno[3,2-d]pyrimidine derivatives as ligands for the serotonergic 5-HT7 receptor 136
DNA intercalators based on (1,10-phenanthrolin-2-yl)isoxazolidin-5-yl core with better growth inhibition and selectivity than cisplatin upon head and neck squamous cells carcinoma 130
Progress in the development of selective heme oxygenase-1 inhibitors and their potential therapeutic application 125
Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis 122
A pseudouridine isoxazolidinyl nucleoside analogue structural analysis: A morphological approach 118
Carbamoyl-Decorated Cyclodextrins for Carbon Dioxide Adsorption 115
Green efficient one‐pot synthesis and separation of nitrones in water assisted by a self‐assembled nanoreactor 113
Design of Small Molecules for Oncological and Neurodegenerative Diseases 111
Mild Friedel–Crafts Reactions inside a Hexameric Resorcinarene Capsule: C−Cl Bond Activation through Hydrogen Bonding to Bridging Water Molecules 111
Functionalization of single and multi-walled carbon nanotubes with polypropylene glycol decorated pyrrole for the development of doxorubicin nano-conveyors for cancer drug delivery 109
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review 106
A structure-and ligand-based virtual screening of a database of “small” marine natural products for the identification of “blue” sigma-2 receptor ligands 106
Antiviral efficacy of heparan sulfate and enoxaparin sodium against SARS-CoV-2 105
Cucurbit[7]uril as a catalytic nanoreactor for one-pot synthesis of isoxazolidines in water 105
Novel structural insight into inhibitors of heme oxygenase-1 (ho-1) by new imidazole-based compounds: Biochemical and in vitro anticancer activity evaluation 101
1,2-Dibenzoylhydrazine as a Multi-Inhibitor Compound: A Morphological and Docking Study 100
Sigma-2 receptor ligands QSAR model dataset 100
New arylethanolimidazole derivatives as HO-1 inhibitors with cytotoxicity against MCF-7 breast cancer cells 99
Targeting heme Oxygenase-1 with hybrid compounds to overcome Imatinib resistance in chronic myeloid leukemia cell lines 98
Development of new HO-1 inhibitors by a thorough scaffold-hopping analysis 98
La modellistica molecolare applicata ai recettori Sigma-1 e Sigma-2: un excursus 97
A Rare Natural Benzo[k,l]xanthene as a Turn-Off Fluorescent Sensor for Cu2+ Ion 96
Chromatograpic resolution of phenylethanolic-azole racemic compounds highlighted stereoselective inhibition of heme oxygenase-1 by (R)-enantiomers 95
Ammidi dell’acido rosmarinico come potenziali agenti antidiabetici 95
Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43 94
Molecular modeling studies of pseudouridine isoxazolidinyl nucleoside analogues as potential inhibitors of the pseudouridine 5'-monophosphate glycosidase 93
Computational tools in the discovery of FABP4 ligands: A statistical and molecular modeling approach 93
Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands 92
Intramolecular oxidative palladium-​catalyzed diamination reactions of alkenyl sulfamates: an efficient synthesis of [1,​2,​5]​thiadiazolo-​fused piperazinones 91
Fourfold filtered statistical/computational approach for the identification of imidazole compounds as HO-1 inhibitors from natural products 91
Artificial Intelligence Technologies for COVID-19 De Novo Drug Design 90
CO2-derived non-isocyanate polyurethanes (NIPUs) and their potential applications 89
The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat 89
Novel Sigma-1 receptor antagonists: From opioids to small molecules: What is new? 88
3D-QSAR assisted identification of FABP4 inhibitors: An effective scaffold hopping analysis/QSAR evaluation 86
γ-Cyclodextrins as Supramolecular Reactors for the Three-component Aza-Darzens Reaction in Water 85
γ-Cyclodextrin as a Catalyst for the Synthesis of 2-Methyl-3,5-diarylisoxazolidines in Water 85
Synthesis of Rosmarinic Acid Amides as Antioxidative and Hypoglycemic Agents 85
Novel Tyrosine Kinase Inhibitors to Target Chronic Myeloid Leukemia 83
Structural, morphological, and modeling studies of N-(benzoyloxy)benzamide as a specific inhibitor of Type II inosine monophosphate dehydrogenase 82
Total Bio-Based Material for Drug Delivery and Iron Chelation to Fight Cancer through Antimicrobial Activity 82
H2 production by solar photoreforming of plastic materials using SiC-g-C3N4composites 82
Synthesis and in vitro evaluation of chlorogenic acid amides as potential hypoglycemic agents and their synergistic effect with acarbose 81
Development of NO-releasing sigma receptor hybrids as anticancer agents 80
Identification of a potent heme oxygenase-2 (HO-2) inhibitor by targeting the secondary hydrophobic pocket of the HO-2 western region 80
Morphing of ibogaine: A successful attempt into the search for sigma-2 receptor ligands 78
Repurposing of FDA-Approved Drugs for Treating Iatrogenic Botulism: A Paired 3D-QSAR/Docking Approach† 78
A hexameric resorcinarene capsule as a hydrogen bonding catalyst in the conjugate addition of pyrroles and indoles to nitroalkenes 78
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 77
Computer-Assisted Design of Peptide-Based Radiotracers 76
Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis 76
‘Main Mechanical Forces‐Chemical Interactions’ Interplay as a Tool to Elucidate Folding Mechanisms 75
Physicochemical characterization and antioxidant activity evaluation of idebenone/hydroxypropyl-β-cyclodextrin inclusion complex 74
Targeting the hydrophobic heme oxygenase-1 western region for the identification of novel and selective azole-based inhibitors. 73
Illuminating the Path to Target GPCR Structures and Functions 72
c-Met Receptor PET Imaging Probes for Cancer Detection and Monitoring 72
Supramolecular biomaterials as drug nanocontainers with iron depletion properties for antimicrobial applications 71
Portable Nanocomposite System for Wound Healing in Space 71
Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors 70
Evidence of enzyme-mediated transesterification of synthetic cannabinoids with ethanol: potential toxicological impact 67
Synergic Interplay Between Halogen Bonding and Hydrogen Bonding in the Activation of a Neutral Substrate in a Nanoconfined Space 67
Nature-inspired innovation: Alginic-kojic acid material for sustainable antibacterial and carbon dioxide fixation 65
An integrated pharmacophore/docking/3D-QSAR approach to screening a large library of products in search of future botulinum neurotoxin a inhibitors 65
Potholing of the hydrophobic heme oxygenase-1 western region for the search of potent and selective imidazole-based inhibitors 65
HEMA-based macro and microporous materials for CO2 capture 64
FABP4 inhibitors 3D-QSAR model and isosteric replacement of BMS309403 datasets 64
Growing the molecular architecture of imidazole-like ligands in HO-1 complexes 64
Benzodiazepine Boom: Tracking Etizolam, Pyrazolam, and Flubromazepam from Pre-UK Psychoactive Act 2016 to Present Using Analytical and Social Listening Techniques 64
Developing Advanced Antibacterial Alginic Acid Biomaterials through Dual Functionalization 63
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022 62
Evidence-based successful example of a structure-based approach for the prediction of designer fentanyl-like molecules 62
Structure-based approach for the prediction of mu-opioid binding affinity of unclassified designer fentanyl-like molecules 62
From far west to east: Joining the molecular architecture of imidazole-like ligands in ho-1 complexes 61
Exploration of nitrogen heterocycle scaffolds for the development of potent human neutrophil elastase inhibitors 60
Targeting the SARS-CoV-2 HR1 with Small Molecules as Inhibitors of the Fusion Process 59
Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. An update from 2017 to early 2022 59
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents 58
The hexameric resorcinarene capsule as an artificial enzyme: Ruling the regio and stereochemistry of a 1,3-dipolar cycloaddition between nitrones and unsaturated aldehydes 58
Supramolecular host-guest interactions of pseudoginsenoside F11 with β- and γ-cyclodextrin: Spectroscopic/spectrometric and computational studies 58
Exploring the Potential Impact of GLP-1 Receptor Agonists on Substance Use, Compulsive Behavior, and Libido: Insights from Social Media Using a Mixed-Methods Approach 57
Design and synthesis of novel compounds as fatty acids binding protein inhibitors and as gallium-68 chelators for positron emission tomography 57
Solvent-free conversion of CO2 in carbonates through a sustainable macroporous catalyst 57
Metyrapone-β-cyclodextrin supramolecular interactions inferred by complementary spectroscopic/spectrometric and computational studies 57
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 55
Learning Strategies from Nature's Blueprint to Cyclic Carbonate Synthesis 55
Designing a monolithic photo-Fenton catalyst using a fungal hydroxypyrone metabolic derivative 55
Conversion of VOC-derived CO2 into sustainable products with a natural magnetic alginate composite 54
TiO2/Loofah–Halloysite Bio–Hybrid Composites as Efficient Systems for VOCs Removal 54
Semaglutide as a Possible Calmodulin Binder: Ligand-Based Computational Analyses and Relevance to Its Associated Reward and Appetitive Behaviour Actions 54
Targeting integrin αvβ6 with gallium-68 tris (hydroxypyridinone) based PET probes 54
Towards identifying nicomorphine administration in doping control: Synthesis of metabolites 54
Halloysite-kojic acid conjugate: A sustainable material for the photocatalytic CO2 reduction and fixation for cyclic carbonates production 54
How can artificial intelligence be utilized for de novo drug design against COVID-19 (SARS-CoV-2)? 53
THP as a sensor for the electrochemical detection of H2O2 51
Current Chemistry behind Peptide-based PET Probes 11C and18F 50
Rosmarinic acid amides: synthesis, α-glucosidase inhibition and enzyme binding mode 50
Efficient green solvent-free CO2/epoxide cycloaddition catalyzed by a β-cyclodextrin-imidazolium-based ionic liquid 49
Tetrazine–trans-cyclooctene ligation: Unveiling the chemistry and applications within the human body 49
Exploring the association between suicidal thoughts, self-injury, and GLP-1 receptor agonists in weight loss treatments: Insights from pharmacovigilance measures and unmasking analysis 49
Totale 7.906
Categoria #
all - tutte 30.772
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.772


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021179 0 0 0 33 55 12 19 8 9 3 23 17
2021/2022486 20 60 27 4 86 6 77 26 38 22 12 108
2022/20231.280 93 80 57 174 107 191 20 182 255 24 68 29
2023/2024910 55 122 68 51 50 183 33 46 33 39 125 105
2024/20253.135 100 452 157 266 506 297 199 149 222 274 248 265
2025/20262.189 444 585 1.046 114 0 0 0 0 0 0 0 0
Totale 8.729